What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...

timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications.

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

View the latest Bruker Corp. (BRKR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Bruker Corporation is a life-sciences company that has delivered returns of 20% annually for the last 15 years, comfortably beating the S&P 500. However, the share price has fallen -34% from its ...

Bruker expects to right-size PhenomeX’s cost structure immediately and expects the acquisition of PhenomeX to be slightly dilutive to Bruker’s non-GAAP EPS in 2024 and 2025, and accretive to ...

Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...

Research Tools & Consumables company Bruker (NASDAQ:BRKR) fell 3.2%. Is now the time to buy Bruker? Access our full analysis report here, it’s free.